AbbVie has announced the European Commission (EC) has granted marketing authorization for ELAHERE (mirvetuximab soravtansine) ...
AbbVie (ABBV) shares snapped eight consecutive sessions of losses as the stock closed up XYZ% at $XYZ. The North ...
Zacks.com on MSN23h
AbbVie's Ovarian Cancer Drug Elahere Gets Approval in EuropeAbbVie ABBV announced that the European Commission (“EC”) has granted marketing authorization to Elahere (mirvetuximab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback